 |
 |
| Hamamatsu's "NanoZoomer" S360MD slide scanner system, which gained FDA marketing approval in 2022. The multi-year agreement with Siemens Healthineers promises a significant expansion of digital pathology deployments, since the Siemens spin-off is a major global player in medical technology. Image: Hamamatsu Photonics. |
| © 2024 SPIE Europe |
|
